Oddity Raises Full-year Forecast, Plans Expansion Into Medical-grade Skin Care With New Telehealth Brand

Oddity Tech, the parent company of Il Makiage and SpoiledChild, raised its full-year forecast once again.

For the full year ending Dec. 31, it is now forecasting net revenue between $799 million and $804million, up from the previous outlook of $790 million to $798 million.

Adjusted diluted earnings per share is expected to come in between $2.06 and $2.09, compared with between the $1.99 and $2.04 previously forecast.

Net revenue rose $241 million in the second quarter ended June 30, from $193 million in the same period of 2024. Analysts had penciled in $238 million.

Net income was $49 million, up from $45 million in the second quarter of 2024, while adjusted diluted EPS were 92 cents, versus 82 cents a year earlier. Wall Street was expecting 84 cents.

Oran Holtzman, Oddity cofounder and CEO, said: “These strong financials allow us to continue reinvesting in our future, including technology, Oddity Labs and building new brands.”

Oddity is gearing up to launch brand three, a telehealth platform for consumers with medical-grade skin and body issues, in the fourth quarter. Brand four is set to be launched next year.

“The upcoming launch of brand three opens up a massive new market for us with the expansion into medical grade products,” Holtzman continued. “Just as we used technology and our direct-to-consumer model to transform beauty, we are turning our sights towards health care, starting with dermatology, where we see a strong and profitable runway.”